Presentations in this conference track covered the latest technological advances and methods in microfluidics devices. In the keynote address “Commercialization and Entrepreneurial Lessons from ...

Explore SLAS Boston 2026 insights on connecting laboratory automation and data infrastructure in drug discovery workflows.

Today, the majority of cell biology operations are carried out manually, even though the core steps are highly reproducible. Staff are expected to conduct repetitive tasks for hours each day, and ...

San Francisco, 06 May 2025: Trilobio, which is building an automated robotic lab-in-a-box for biologists, today announced it has raised $8 million USD Seed investment. The oversubscribed round was led ...

Trilobio, the Company building the fully automated robotic lab-in-a-box for biologists, today announced it has raised $8 million USD Seed investment. The oversubscribed round was led by Initialized ...

When automation technology first became available for drug discovery, the equipment was expensive and fairly complex to use, and needed a lot of attention and maintenance to stay up-and-running. This ...

Opentrons, a leader in lab automation, announces the launch of its Opentrons Flex robot, a new generation of affordable and easy-to-program liquid-handling lab robots designed to level the playing ...

Granted by the United States Patent and Trademark Office, with extensions filed globally, the patent covers an approach that gives laboratories the ability to increase productivity for time and cost ...

Artificial Intelligence (AI) is being viewed as a way to program automation in laboratories, which leaves questions about the relevance and impact of the role of automation specialists in light of ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Strateos, Inc., a pioneer in the development of remote access laboratories and lab automation software for life science research, today announced the availability ...

Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. No topic has been discussed more than Covid-19 in the past two ...